Aurobindo USA is committed to delivering a broad portfolio of quality, affordable generic pharmaceuticals to pharmacists and patients. Since its first US ANDA approval in 2004, Aurobindo has expanded its portfolio to include more than 150 product families, representing a wide range of therapeutic categories.

Aurobindo has been recognized as the fastest growing pharmaceutical company in 2012,* and in early 2013, thanks to the ongoing support of our customers, became one of the top 10 pharmaceutical companies, brand or generic, in terms of total prescriptions dispensed.**

Biotechnology

Pharmaceutical

Aurobindo Pharma USA, Inc.

Swami Iyer

Yedunandan Karri

Carson Brotz

Vijay Bhaskar Reddy Kondakkagari

Nidhi Patel

Nandita Goel

Mani Sagar Naidu

Alexander Testa

Rohit Ghan Ph.D.

Jennifer Perry (Siverling)

Rajeev Tl

Nehal Bhatt

Blessy Johns

Jamie Downey

David Palew

Paul McMahon

Amy Farris Wolfe

Theresa Perniciaro

Biren Shah

The Research and Development team at Aurobindo Pharma USA, Inc. is dedicated to innovating and enhancing pharmaceutical formulations to ensure the delivery of high-quality generic medications. This multidisciplinary group of scientists collaborates on product development, formulation optimization, and process improvements across a diverse range of therapeutic areas, working to expand Aurobindo's extensive portfolio and maintain its competitive edge in the pharmaceutical market.

Research and Development

Leadership Team

Quality Assurance and Compliance

Research and Development

About

Team members

Other teams at Aurobindo Pharma USA, Inc.

Leadership Team

Quality Assurance and Compliance